Guanidinoacetic acid deficiency: A new entity in clinical medicine?

15Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Guanidinoacetic acid (GAA, also known as glycocyamine or betacyamine) is a naturally-occurring derivative of glycine and a direct metabolic precursor of creatine, a key player in high-phosphate cellular bioenergetics. GAA is found in human serum and urine, with circulating GAA likely reflects an equilibrium between its endogenous production and utilization/excretion. GAA deficiency (as indicated by low serum GAA) has been reported in various conditions yet this intriguing clinical entity appears to be poorly characterized as yet, either as a primary deficit or a sequel of secondary disease. This minireview article summarizes the inherited and acquired disorders with apparent GAA deficiency and discusses a possible relevance of GAA shortfall in clinical medicine.

Cite

CITATION STYLE

APA

Ostojic, S. M., Ratgeber, L., Olah, A., Betlehem, J., & Acs, P. (2020). Guanidinoacetic acid deficiency: A new entity in clinical medicine? International Journal of Medical Sciences, 17(16), 2544–2550. https://doi.org/10.7150/ijms.47757

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free